Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
The Nuclear Regulatory Commission (NRC) is revising its 1979 policy statement on the medical use of byproduct material.  These revisions are one component of the Commission's overall program for revising its regulatory framework for medical use, including its regulations that govern the medical use of byproduct material.  The overall goals of this program are to focus NRC regulation of medical use on those medical procedures that pose the highest risk and to structure its regulations to be risk-informed and more performance-based, consistent with NRC's "Strategic Plan for Fiscal Year 1997-Fiscal Year 2002." The policy informs NRC licensees, other Federal and State agencies, and the public of the Commission's general intentions in regulating the medical use of byproduct material.
D006077:Government Agencies / Q000331:legislation & jurisprudence; D006801:Humans; D009683:Nuclear Medicine / Q000331:legislation & jurisprudence* / Q000592:standards; D011835:Radiation Protection / Q000331:legislation & jurisprudence / Q000592:standards; D011868:Radioisotopes / Q000592:standards* / Q000627:therapeutic use; D014481:United States
D011868:Radioisotopes